These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3565076)

  • 21. Dopamine negatively modulates its own blood pressure increasing action.
    Kuchel O; Buu NT; Serri O
    Can J Cardiol; 1987; 3(1):18-22. PubMed ID: 3828892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dopamine in segmental intestinal ischaemia studied with dopamine receptor blockers.
    Gustafsson G
    Acta Chir Scand; 1984; 150(2):145-51. PubMed ID: 6720222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinogen-fibrin degradation products.
    Kwaan HC
    Ann Clin Lab Sci; 1980; 10(3):234-7. PubMed ID: 7396389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone.
    Cavero I; Lefèvre-Borg F; Gomeni R
    J Pharmacol Exp Ther; 1981 Aug; 218(2):515-24. PubMed ID: 7252851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
    Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
    Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of the antihypertensive action of DL-alpha-monofluoromethyldopa: implications for the role of the sympathetic nervous system in maintenance of elevated blood pressure in spontaneously hypertensive rats.
    Fozard JR; Möhring J; Palfreyman MG; Koch-Weser J
    J Cardiovasc Pharmacol; 1981; 3(5):1038-49. PubMed ID: 6168849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of Ang II and renal sympathetic nerve influence dopamine-and isoprenaline-induced renal haemodynamic changes in normal Wistar-Kyoto and spontaneously hypertensive rats.
    Abdulla MH; Sattar MA; Abdullah NA; Hazim AI; Anand Swarup KR; Rathore HA; Khan MA; Johns EJ
    Auton Autacoid Pharmacol; 2008 Oct; 28(4):95-101. PubMed ID: 18778332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of vitamin E on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Furukawa Y; Murakami M; Watanabe K; Kondo M
    Thromb Haemost; 1982 Oct; 48(2):235-7. PubMed ID: 7179203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
    Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of superoxide dismutase and catalase on disseminated intravascular coagulation in rats.
    Yoshikawa T; Murakami M; Yoshida N; Seto O; Kondo M
    Thromb Haemost; 1983 Dec; 50(4):869-72. PubMed ID: 6665768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissociation of changes in the permeability of the blood-brain barrier from catecholamine-induced changes in blood pressure of normotensive and spontaneously hypertensive rats.
    Sankar R; Domer FR; Taylor B
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):343-54. PubMed ID: 7178648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanism of fibrinolysis (review of the literature)].
    Kovalenko AN
    Vrach Delo; 1983 Jan; (1):10-5. PubMed ID: 6223445
    [No Abstract]   [Full Text] [Related]  

  • 33. [Relations between products of fibrin degradation and arterial blood pressure in pregnancy complicated by nephropathy].
    Tsitsiashvili ESh
    Lab Delo; 1982; (4):230-2. PubMed ID: 6177910
    [No Abstract]   [Full Text] [Related]  

  • 34. Some pharmacological and biochemical effects of fibrinopeptides A and B in the circulatory system of rats.
    Antecka-Genadiew E; Buczko W; Stasiak A; Maciejewski A; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(5):359-66. PubMed ID: 6664938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The beta 2 receptor plays a role in the hypotensive effect of L-dopa.
    Quevedo M; Prieto JC; Pérez-Olea J
    Acta Physiol Pharmacol Ther Latinoam; 1995; 45(1):19-25. PubMed ID: 8580515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fragment E derived from both fibrin and fibrinogen stimulates interleukin-6 production in rat peritoneal macrophages.
    Lee ME; Rhee KJ; Nham SU
    Mol Cells; 1999 Feb; 9(1):7-13. PubMed ID: 10102564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinogen degradation products do not affect the hypertensive action of dopamine.
    Buczko W; Wiśniewski K
    Acta Med Pol; 1986; 27(1-2):31-6. PubMed ID: 3565076
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of products of degradation of fibrinogen A and B on the arterial blood pressure in the rat.
    Barczak-Osińska J; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(4):279-83. PubMed ID: 6664935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of effects of fibrinogen degradation products on specific binding of [3H]spiroperidol and [3H]ADTN.
    Buczko W; De Blasi A
    Pol J Pharmacol Pharm; 1983; 35(1):45-7. PubMed ID: 6889186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of fibrinopeptides A and B on the circulatory action of dopamine.
    Barczak-Osińska J; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(4):285-92. PubMed ID: 6664936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.